Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Gly-Gly-Phe-Gly (GGFG): Benchmarking a Flexible Peptide Link
2026-06-29
Gly-Gly-Phe-Gly (GGFG) is a short, flexible peptide linker widely used in drug conjugation research and antibody-drug conjugate development. Its high purity and reliable linker properties make it a preferred tool for peptide engineering, with evidence supporting its role in optimizing bioconjugation strategies.
-
Capsaicin for TRPV1 and KDM1A: Workflows, Insights & Trouble
2026-06-29
Capsaicin (E)-Capsaicin uniquely bridges pain signaling and epigenetic modulation, making it a powerful tool for both neurobiology and cancer research. This guide distills validated protocols, advanced applications, and troubleshooting strategies to maximize experimental reliability and translational impact.
-
WEHI-539: Precision BCL-XL Inhibition for Decoding Apoptotic
2026-06-28
Explore how WEHI-539, a potent BCL-XL inhibitor, is uniquely enabling advanced dissection of apoptotic resistance, with deep insights into assay design and translational applications. Learn what sets this molecule—and this approach—apart in cancer and stem cell research.
-
Structural Mechanisms and Affinity Tuning in CD38 CAR Binder
2026-06-27
The reference study provides a detailed structural and functional analysis of two CD38-targeting CAR binders, RP02 and 028, uncovering distinct modes of antigen engagement and mechanisms for rational affinity tuning. These insights inform the design of safer, more selective CAR-T therapies for hematologic malignancies by balancing antitumor potency with reduced off-tumor toxicity.
-
Structural Basis and Affinity Tuning of CD38 CAR Binders
2026-06-26
This study provides a structural and functional dissection of two CD38-targeting CAR binders, revealing distinct modes of antigen engagement and enzymatic inhibition. By mapping precise epitope interactions and demonstrating rational affinity modulation, the work informs safer and more selective CAR-T cell therapies for hematologic malignancies.
-
Nirmatrelvir (PF-07321332): Optimizing SARS-CoV-2 Inhibition
2026-06-26
Nirmatrelvir (PF-07321332), a rigorously validated SARS-CoV-2 3CL protease inhibitor from APExBIO, empowers researchers with precision tools for dissecting coronavirus replication. This guide unpacks protocol enhancements, advanced use-cases, and troubleshooting insights to accelerate antiviral research and maximize assay reproducibility.
-
Poly(I:C): Strategic Leverage in Translational Immunology
2026-06-25
Explore how Poly(I:C), a synthetic double-stranded RNA analog and TLR3 agonist, is reshaping translational research. This article blends mechanistic insight with workflow strategy, highlighting dose-dependent immune activation, dendritic cell maturation, and emerging applications across immunology and antiviral research. Drawing from recent evidence and best practices, it offers actionable guidance for driving innovation with APExBIO’s Poly(I:C).
-
Propidium Iodide: Advanced DNA Intercalating Dye for Cell An
2026-06-25
Propidium iodide (PI) stands as a gold-standard DNA intercalating dye for robust cell viability assays, apoptosis detection, and cell cycle analysis. This article deciphers cutting-edge workflows, translates insights from recent immunology research, and delivers actionable troubleshooting for reliable, high-sensitivity results in complex cellular systems.
-
Malate ((S)-2-hydroxysuccinic acid) in TCA Cycle Assays
2026-06-24
Malate ((S)-2-hydroxysuccinic acid) empowers metabolic, redox, and immunometabolic research with precise modulation of the TCA cycle. APExBIO’s high-purity malate enables advanced assay workflows, dissecting both mitochondrial dynamics and tumor microenvironmental crosstalk.
-
G-1: Selective GPR30 Agonist for Advanced Cardiovascular and
2026-06-23
G-1 (CAS 881639-98-1) empowers precise activation of GPR30, unlocking superior selectivity and reproducibility in both cardiovascular and cancer assays. This guide distills workflow optimizations, troubleshooting tactics, and actionable insights from recent literature, positioning G-1 as an indispensable tool for dissecting rapid estrogen signaling and advancing translational research.
-
G-1: Selective GPR30 Agonist Empowering Translational Resear
2026-06-23
G-1 enables researchers to dissect rapid, non-classical estrogen signaling with unmatched selectivity, fueling breakthroughs in cardiovascular and oncology models. This article delivers practical experimental workflows, troubleshooting guidance, and actionable insights to maximize the reliability and impact of GPR30-targeted studies with G-1.
-
γH2AX DNA Damage Detection Kit: Precision in DNA DSB Detecti
2026-06-22
The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) enables precise identification of DNA double-strand breaks via γ-H2AX immunofluorescence. This product is a robust tool for DNA damage and repair research, validated across multiple models and workflows. APExBIO’s kit offers high sensitivity for applications in genotoxicity, apoptosis assays, and cancer research.
-
Mycophenolic Acid: Reliable Dehydrogenase Inhibitor for Assa
2026-06-22
This article explores real-world laboratory scenarios where Mycophenolic acid (SKU B1981) addresses critical challenges in cell viability, immune modulation, and assay reproducibility. Drawing on protocol advances and peer-reviewed evidence, it demonstrates how researchers can achieve reliable, sensitive, and interpretable results using this research-grade dehydrogenase inhibitor. Practical Q&A blocks, protocol parameters, and candid product selection insights equip biomedical scientists with actionable strategies for immunometabolic research.
-
Eicosapentaenoic Acid: Protocols and Troubleshooting in Rese
2026-06-21
Eicosapentaenoic Acid (EPA) is a gold-standard omega-3 fatty acid for cardiovascular and immunomodulatory research, offering reproducible lipid-lowering and anti-inflammatory effects. This guide delivers actionable workflows, comparative advantages, and troubleshooting strategies—bridging reference breakthroughs with hands-on laboratory optimization.
-
Rapid Purification of Recombinant Annexin V for Biophysical
2026-06-20
This study introduces a streamlined protocol for purifying recombinant annexin V, leveraging calcium-mediated liposome binding and mild bacterial cell lysis. The method addresses the challenge of obtaining highly pure protein for precise ion channel and structural analyses, supporting advanced biophysical research.